Prostate Cancer Advances: Opaganib Trial, Age-Mortality Link, and AI Detection Tools
Jun 24, 2026
Recent prostate cancer research includes a Phase 2 trial of opaganib in advanced disease, a SEER study linking older age to higher mortality in bone-only metastases, and AI and genetic tools that improve detection.